The following is a summary of “Efficacy and safety of novel anticoagulant therapies in patients with chronic kidney disease—a systematic review and meta-analysis,” published in the November 2024 issue ...
Around one hundred people a month in England have avoided a stroke over the last year thanks to a lifesaving NHS rollout of blood thinning medication. Over the last year, one million people with ...
The researchers conducted a randomized trial comparing extended anticoagulation with reduced-dose versus full-dose direct oral anticoagulants in patients with venous thromboembolism. HealthDay ...
Forbes Advisor receives compensation from partner links on this page. Online bets are not legal in all locations, and this content is meant for those 21+. Winnings are not guaranteed, and you may ...
AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.